US Stocks
/
Atara Biotherapeutics, Inc. Share Price

Atara Biotherapeutics, Inc. Share Price

NASDAQ: ATRA | Micro Cap
$8.47
+$0.11 (1.32%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Atara Biotherapeutics, Inc. Stock Performance

Open
$8.40
Prev. Close
$8.36
Circuit Range
N/A
Day Range
$8.27 - $8.40
Year Range
$3.93 - $18.84
Volume
908
Average Traded
$8.35

Atara Biotherapeutics, Inc. Share Price Today

As of 10 August 2026, Atara Biotherapeutics, Inc.'s share price is $8.47. The stock opened at $8.40, compared to its previous close of $8.36. During today's trading session, Atara Biotherapeutics, Inc.'s share price traded between $8.27 and $8.40, with an average price of $8.34. Over the past 52 weeks, the stock has recorded a high of $18.84 and a low of $3.93. In terms of performance, Atara Biotherapeutics, Inc.'s share price has risen by 57.14% over the last six months and is down 31.50% on a year-on-year basis.

Atara Biotherapeutics, Inc. Share Price Chart

$8.27$8.40
L
Show Current Price
H

Atara Biotherapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$106.25M
PE Ratio (TTM)
3.25
Dividend Yield
N/A
EPS (TTM)
$2.61
Revenue (TTM)
$120.77M
Return On Equity (TTM)
-84.90%
Profit Margin
27.07%
Debt to Equity
-0.39
Quarterly Earnings Growth YoY
219.71%

Atara Biotherapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025
RevenueN/A$28.64M$40.19MN/A
Net Profit-$31.75M-$19.05M-$21.91M$38.01M
Net Profit MarginN/A-66.51%-54.51%N/A
Income ChangeN/A40.01%-15.01%273.49%

Atara Biotherapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/A$8.57M$128.94M$120.77M
Net Profit-$340.14M-$228.30M-$276.13M-$85.40M$32.69M
Net Profit MarginN/AN/A-3220.88%-66.23%27.07%
Income ChangeN/A32.88%-20.95%69.07%138.28%

About Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.

Atara Biotherapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$8.42
$8.39
-0.89%
Jul 2026
$11.59
$8.46
-26.13%
Jun 2026
$10.25
$11.46
+9.30%
May 2026
$4.73
$10.48
+115.08%
Apr 2026
$4.87
$4.88
+1.56%
Mar 2026
$5.04
$4.80
-10.95%
Feb 2026
$5.16
$5.39
+4.26%
Jan 2026
$18.84
$5.17
-71.32%
Dec 2025
$14.43
$18.02
+20.49%
Nov 2025
$14.57
$14.96
+6.14%
Oct 2025
$14.60
$14.10
+0.89%
Sep 2025
$12.53
$13.97
+12.98%

ATRA Share Price FAQs

What is Atara Biotherapeutics, Inc. share price today?

chevron-up
Atara Biotherapeutics, Inc. share price today is $8.47 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Atara Biotherapeutics, Inc. stock?

chevron-up
The 52 week high of Atara Biotherapeutics, Inc. stock is $18.84, while the 52 week low is $3.93 as of 8 Aug '26.

What is ATRA's market capitalisation today?

chevron-up
ATRA market capitalisation is $106.25M as of August 10, 2026, at 12:07 pm IST.

What is ATRA's net income for the last quarter?

chevron-up
ATRA's net income for the last quarter is 0.04B USD.

What is the 5 year returns of ATRA?

chevron-up
The 5 year returns of ATRA is -97.74% as on 8 Aug '26.

What is the high & low stock price of ATRA today?

chevron-up
ATRA stock price hit a high of $8.40 and low of $8.27 as of 8 Aug '26.

Can I buy ATRA shares in India?

chevron-up
Yes. You can buy ATRA in India by opening an international trading account.